Evidence map›Paper›PMID 35997578›Full record

ArticleEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery2022

Left ventricular assist device-related infections and the risk of cerebrovascular accidents: a EUROMACS study.

Casper F Zijderhand, Christiaan F J Antonides, Kevin M Veen, Nelianne J Verkaik, Felix Schoenrath, Jan Gummert, Petr Nemec, Béla Merkely, Francesco Musumeci, Bart Meyns and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Current issues of destination therapy in Japan: to achieve 5-year or even longer survival.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2024
    Review
  5. Review
  6. Strategies for surface coatings of implantable cardiac medical devices.Frontiers in bioengineering and biotechnology · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 6 countries.

Casper F ZijderhandThoraxcenter, Department of Cardiothoracic Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Christiaan F J AntonidesThoraxcenter, Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Kevin M VeenThoraxcenter, Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Nelianne J VerkaikDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Felix SchoenrathDepartment of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.ORCID 0000-0002-8221-1295
Jan GummertClinic for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center, NRW, Ruhr University Bochum, Bad Oeynhausen, Germany.
Petr NemecDepartment of Internal Cardiology Medicine, Marasyk University, Brno, Czech Republic.ORCID 0000-0002-4542-913X
Béla MerkelyHeart and Vascular Center, Semmelweis University, Budapest, Hungary.
Francesco MusumeciDepartment of Heart and Vessels, Cardiac Surgery Unit and Heart Transplantation Center, S. Camillo-Forlanini Hospital, Roma, Italy.ORCID 0000-0002-3617-5916
Bart MeynsDepartment of Cardiac Surgery, University Hospitals Leuven, Leuven, Belgium.ORCID 0000-0002-8110-4009
Theo M M H de ByEUROMACS, European Association for Cardio-Thoracic Surgery (EACTS), Windsor, UK.
Ad J J C BogersThoraxcenter, Department of Cardiothoracic Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.ORCID 0000-0001-6200-1998
Kadir CaliskanThoraxcenter, Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.ORCID 0000-0002-3293-9261
Erasmus MC · NLCarlo Forlanini Hospital · ITDeutsches Herzzentrum der Charité · DEHeart and Diabetes Center North Rhine-Westphalia · DEKU Leuven · BEMasaryk University · CZSemmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIn patients supported by a durable left ventricular assist device (LVAD), infections are a frequently reported adverse event with increased morbidity and mortality. The purpose of this study was to investigate the possible association between infections and thromboembolic events, most notable cerebrovascular accidents (CVAs), in LVAD patients.

methodsAn analysis of the multicentre European Registry for Patients Assisted with Mechanical Circulatory Support was performed. Infections were categorized as VAD-specific infections, VAD-related infections and non-VAD-related infections. An extended Kaplan-Meier analysis for the risk of CVA with infection as a time-dependent covariate and a multivariable Cox proportional hazard model were performed.

resultsFor this analysis, 3282 patients with an LVAD were included with the majority of patients being male (83.1%). During follow-up, 1262 patients suffered from infection, and 457 patients had a CVA. Cox regression analysis with first infection as time-dependent covariate revealed a hazard ratio (HR) for CVA of 1.90 [95% confidence interval (CI): 1.55-2.33; P < 0.001]. Multivariable analysis confirmed the association for infection and CVAs with an HR of 1.99 (95% CI: 1.62-2.45; P < 0.001). With infections subcategorized, VAD-specific HR was 1.56 (95% CI: 1.18-2.08; P 0.002) and VAD-related infections [HR: 1.99 (95% CI: 1.41-2.82; P < 0.001)] remained associated with CVAs, while non-VAD-related infections (P = 0.102) were not.

conclusionsInfection during LVAD support is associated with an increased risk of developing an ischaemic or haemorrhagic CVA, particularly in the setting of VAD-related or VAD-specific infections. This suggests the need of a stringent anticoagulation management and adequate antibiotic treatment during an infection in LVAD-supported patients.

Indexed as

Heart-Assist DevicesHeart FailureStrokeAnti-Bacterial AgentsAnticoagulantsFemaleHumansMaleRegistriesRetrospective StudiesTreatment OutcomeAnti-Bacterial AgentsAnticoagulantsCerebrovascular accidentsHeart failureInfectionLeft ventricular assist deviceThromboembolic events

Identifiers

PMID35997578
PMCPMC9536286
OpenAlexW4292723317

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.